Global Anti-Infective Vaccines Market – Analysis By Disease Type (Bacterial, Viral), By Region, By Country: Opportunities and Forecasts (2016-2021) - By Vaccine Type (Anti- Bacterial, Anti-Viral); Diseases-Types (TB, Typhoid, Influenza, Others), By Region (North America, Europe, APAC, ROW); By Country (USA, Canada, UK, France, India, China)
Executive Summary
Surging old age population, rising polluted drinking water, development of bioterrorism combined with rising technological development in vaccine industry, growing awareness towards individual health along with initiative taken by various government and non-government institutions have been driving the demand for anti-infective vaccines.Rising incidences of typhoid, TB, hepatitis and other virus borne diseases will drive the market for anti-infective vaccines market. Further, rising concerns over bioterrorism due to biological weapons along with increasing focus on the immunization programmes for prevention of diseases have been contributing in the growth of Anti Infective Vaccines.
Among the types of bacterial diseases, market is expected to be driven by typhoid and TB, mainly due to high number of cases in developing regions. However, antiviral vaccines will continue to generate major revenue due to increases R&D expenses along with rising number cases for various diseases like Influenza and ZIKA virus in developed regions.While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastructure and rising focus on healthcare among the growing middle class population along with escalating expenditure on immunization programmes by various NGO’s.
Global Anti- infective vaccine Market is forecasted to grow at a CAGR of 5.88% during 2016 – 2021F, on account of rising incidences of typhoid, TB, hepatitis and Influenza among the growing population across the globe. North America region remains the major market followed by Europe in the actual period, while APAC and ROW region will witness strong growth in the forecast period.
According to Azoth Analytics research report, "Global Anti-Infective Vaccines Market – Analysis By Disease Type (Bacterial, Viral), By Region, By Country: Opportunities and Forecasts (2016-2021)", Global Anti-Infective Vaccine market is projected to exhibit a CAGR of over ~5.88% during 2016 - 2021.
Scope of the Report
The report provides Segmentation by Vaccine Type
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
Surging old age population, rising polluted drinking water, development of bioterrorism combined with rising technological development in vaccine industry, growing awareness towards individual health along with initiative taken by various government and non-government institutions have been driving the demand for anti-infective vaccines.Rising incidences of typhoid, TB, hepatitis and other virus borne diseases will drive the market for anti-infective vaccines market. Further, rising concerns over bioterrorism due to biological weapons along with increasing focus on the immunization programmes for prevention of diseases have been contributing in the growth of Anti Infective Vaccines.
Among the types of bacterial diseases, market is expected to be driven by typhoid and TB, mainly due to high number of cases in developing regions. However, antiviral vaccines will continue to generate major revenue due to increases R&D expenses along with rising number cases for various diseases like Influenza and ZIKA virus in developed regions.While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastructure and rising focus on healthcare among the growing middle class population along with escalating expenditure on immunization programmes by various NGO’s.
Global Anti- infective vaccine Market is forecasted to grow at a CAGR of 5.88% during 2016 – 2021F, on account of rising incidences of typhoid, TB, hepatitis and Influenza among the growing population across the globe. North America region remains the major market followed by Europe in the actual period, while APAC and ROW region will witness strong growth in the forecast period.
According to Azoth Analytics research report, "Global Anti-Infective Vaccines Market – Analysis By Disease Type (Bacterial, Viral), By Region, By Country: Opportunities and Forecasts (2016-2021)", Global Anti-Infective Vaccine market is projected to exhibit a CAGR of over ~5.88% during 2016 - 2021.
Scope of the Report
The report provides Segmentation by Vaccine Type
- Anti- Bacterial
- Anti- Viral
- Anti- Bacterial- Diseases Type, TB Typhoid and Other’s
- Anti- Viral Type- Diseases Type, Hepatitis, Influenza and Other’s
- North America
- Europe
- Asia Pacific
- ROW
- USA
- Canada
- UK
- France
- India
- China
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
1. RESEARCH METHODOLOGY
2. EXECUTIVE SUMMARY
3. STRATEGIC RECOMMENDATION
3.1. Escalate the focus on the Asia Pacific Region
3.2. Focus on R&D
4. GLOBAL ANTI-INFECTIVE VACCINES MARKET: PRODUCT OVERVIEW
5. GLOBAL ANTI-INFECTIVE VACCINES MARKET: GROWTH AND FORECAST
5.1 Global Anti-infective Vaccines Market
5.1.1. By Value (Historic 2011-15)
5.1.2. By Value ( Forecast 2016E-2021F)
6. GLOBAL ANTI-BACTERIAL VACCINES MARKET: GROWTH AND FORECAST
6.1 Global Anti-Bacterial Vaccines Market
6.1.1. By Value(Historic 2011-15)
6.1.2 By Value( Forecast 2016E-2021F)
7. GLOBAL ANTI-VIRAL VACCINES MARKET: GROWTH AND FORECAST
7.1 Global Anti-Viral Vaccines Market
7.1.1 By Value(Historic 2011-15)
7.1.2 By Value( Forecast 2016E-2021F)
8. GLOBAL ANTI-INFECTIVE VACCINES MARKET - BY DISEASE
8.1 Global Typhoid Vaccines Market
8.1.1. By Value-Actual(2015)
8.1.2. By Value-Forecast(2021)
8.2 Global Tuberculosis Vaccines Market
8.2.1. By Value-Actual(2015)
8.2.2. By Value -Forecast(2021)
8.3 Global Other Anti-Bacterial Vaccines Market
8.3.1. By Value-Actual(2015)
8.3.2 By Value- Forecast (2021)
8.4 Global Influenza Vaccines Market
8.4.1. By Value-Actual(2015)
8.4.2 By Value- Forecast (2021)
8.5 Global Hepatitis Vaccines Market
8.5.1 By Value-Actual(2015)
8.5.2 By Value- Forecast (2021)
8.6 Global Other Anti-Viral Vaccines Market
8.6.1 By Value-Actual(2015)
8.6.2 By Value- Forecast (2021)
9. GLOBAL ANTI-INFECTIVE VACCINES- PIPELINE ANALYSIS
9.1 Typhoid Vaccines
9.2 Tuberculosis Vaccines
9.3 Tetanus & Diptheria Vaccines
9.4 Other Anti-Bacterial Vaccines
9.5 Influenza Vaccines
9.6 Hepatitis Vaccines
9.7 Polio Vaccines
9.8 Other Anti-Viral Vaccines
10. NORTH AMERICA ANTI-INFECTIVE VACCINES MARKET: SIZING AND GROWTH
10.1 By Value-Actual(2015)
10.2 By Value- Forecast (2021)
10.3 North America Anti-Bacterial Vaccines Market
10.3.1 By Value-Actual(2015)
10.3.2 By Value- Forecast (2021)
10.4 North America Anti-Viral Vaccines Market
10.4.1 By Value-Actual(2015)
10.4.2 By Value Forecast ( 2016-2021)
11. NORTH AMERICA ANTI-INFECTIVE VACCINES MARKET- BY DISEASE
11.1 North America Typhoid Vaccines Market
11.1.1 By Value-Actual(2015)
11.1.2 By Value- Forecast (2021)
11.2 North America Tuberculosis Vaccines Market
11.2.1 By Value-Actual(2015)
11.2.2 By Value- Forecast (2021)
11.3 North America Other Anti-Bacterial Vaccines Market
11.3.1 By Value-Actual(2015)
11.3.2 By Value- Forecast (2021)
11.4 North America Influenza Vaccines Market
11.4.1 By Value-Actual(2015)
11.4.2 By Value- Forecast (2021)
11.5 North America Hepatitis Vaccines Market
11.5.1 By Value – Actual ( 2011-2015)
11.5.2 By Value Forecast ( 2016-2021)
11.6 North America Other Anti-Viral Vaccines Market
11.6.1 By Value-Actual(2011-2015)
11.6.2 By Value- Forecast (2016-2021)
11.7 US Anti-Infective Vaccines Market
11.7.1 By Value-Actual(2011-2015)
11.7.2 By Value- Forecast (2016-2021)
11.8 US Anti-Bacterial Vaccines Market
11.8.1 By Value-Actual(2011-2015)
11.8.2 By Value- Forecast (2016-2021)
11.9 US Anti-Viral Vaccines Market
11.9.1 By Value-Actual(2015)
11.9.2 By Value- Forecast (2021)
11.10 Canada Anti-Infective Vaccines Market
11.10.1 By Value-Actual(2011-2015)
11.10.2 By Value- Forecast (2016-2021)
11.13 North America Others Market
11.13.1 By Value-Actual(2011-2015)
11.13.2 By Value- Forecast (2016-2021)
12. EUROPE ANTI-INFECTIVE VACCINES MARKET: SIZING AND GROWTH
12.1 By Value-Actual(2015)
12.2 By Value- Forecast (2021)
12.3 Europe Anti-Bacterial Vaccines Market
12.3.1 By Value-Actual(2015)
12.3.2 By Value- Forecast (2021)
12.4 Europe Anti-Viral Vaccines Market
12.4.1 By Value-Actual(2015)
12.4.2 By Value Forecast ( 2016-2021)
13. EUROPE ANTI-INFECTIVE VACCINES MARKET- BY DISEASE
13.1 Europe Typhoid Vaccines Market
13.1.1 By Value-Actual(2015)
13.1.2 By Value- Forecast (2021)
13.2 Europe Tuberculosis Vaccines Market
13.2.1 By Value-Actual(2015)
13.2.2 By Value- Forecast (2021)
13.3 Europe Other Anti-Bacterial Vaccines Market
13.3.1 By Value-Actual(2015)
13.3.2 By Value- Forecast (2021)
13.4 Europe Influenza Vaccines Market
13.4.1 By Value-Actual(2015)
13.4.2 By Value- Forecast (2021)
13.5 Europe Hepatitis Vaccines Market
13.5.1 By Value – Actual ( 2011-2015)
13.5.2 By Value Forecast ( 2016-2021)
13.6 Europe Other Anti-Viral Vaccines Market
13.6.1 By Value-Actual (2011-2015)
13.6.2 By Value- Forecast (2016-2021)
13.7 UK Anti-Infective Vaccines Market
13.7.1 By Value-Actual(2011-2015)
13.7.2 By Value- Forecast (2016-2021)
13.8 UK Anti-Bacterial Vaccines Market
13.8.1 By Value-Actual(2011-2015)
13.8.2 By Value- Forecast (2016-2021)
13.9 UK Anti-Viral Vaccines Market
13.9.1 By Value-Actual(2015)
13.9.2 By Value- Forecast (2021)
13.10 France Anti-Infective Vaccines Market
13.10.1 By Value-Actual(2011-2015)
13.10.2 By Value- Forecast (2016-2021)
13.11 France Anti-Bacterial Vaccines Market
13.11.1 By Value-Actual(2011-2015)
13.11.2 By Value- Forecast (2016-2021)
13.12 France Anti-Viral Vaccines Market
13.12.1 By Value-Actual (2015)
13.12.2 By Value- Forecast (2021)
13.13 Europe Others Market
13.13.1 By Value-Actual(2011-2015)
13.13.2 By Value- Forecast (2016-2021)
14. APAC ANTI-INFECTIVE VACCINES MARKET: SIZING AND GROWTH
14.1 By Value-Actual(2015)
14.2 By Value- Forecast (2021)
14.3 APAC Anti-Bacterial Vaccines Market
14.3.1 By Value-Actual(2015)
14.3.2 By Value- Forecast (2021)
14.4 Europe Anti-Viral Vaccines Market
14.4.1 By Value-Actual(2015)
14.4.2 By Value Forecast ( 2016-2021)
15. APAC ANTI-INFECTIVE VACCINES MARKET- BY DISEASE
15.1 APAC Typhoid Vaccines Market
15.1.1 By Value-Actual(2015)
15.1.2 By Value- Forecast (2021)
15.2 APAC Tuberculosis Vaccines Market
15.2.1 By Value-Actual(2015)
15.2.2 By Value- Forecast (2021)
15.3 APAC Other Anti-Bacterial Vaccines Market
15.3.1 By Value-Actual(2015)
15.3.2 By Value- Forecast (2021)
15.4 APAC Influenza Vaccines Market
15.4.1 By Value-Actual(2015)
15.4.2 By Value- Forecast (2021)
15.5 APAC Hepatitis Vaccines Market
15.5.1 By Value – Actual ( 2011-2015)
15.5.2 By Value Forecast ( 2016-2021)
15.6 APAC Other Anti-Viral Vaccines Market
15.6.1 By Value-Actual(2011-2015)
15.6.2 By Value- Forecast (2016-2021)
15.7 India Anti-Infective Vaccines Market
15.7.1 By Value-Actual(2011-2015)
15.7.2 By Value- Forecast (2016-2021)
15.8 India Anti-Bacterial Vaccines Market
15.8.1 By Value-Actual(2011-2015)
15.8.2 By Value- Forecast (2016-2021)
15.9 India Anti-Viral Vaccines Market
15.9.1 By Value-Actual(2015)
15.9.2 By Value- Forecast (2021)
15.10 China Anti-Infective Vaccines Market
15.10.1 By Value-Actual(2011-2015)
15.10.2 By Value- Forecast (2016-2021)
15.11 China Anti-Bacterial Vaccines Market
15.11.1 By Value-Actual(2011-2015)
15.11.2 By Value- Forecast (2016-2021)
15.12 China Anti-Viral Vaccines Market
15.12.1 By Value-Actual(2015)
15.12.2 By Value- Forecast (2021)
15.13 APAC Others Market
15.13.1 By Value-Actual(2011-2015)
15.13.2 By Value- Forecast (2016-2021)
16. ROW ANTI-INFECTIVE VACCINES MARKET
16.1 By Value-Actual(2015)
16.2 By Value- Forecast (2021)
17. MARKET DYNAMICS
17.1. Drivers
17.2. Challenges
17.3. Trends
18. POLICY AND REGULATORY LANDSCAPE
19. COMPETITIVE LANDSCAPE
19.1. Company Profiles
19.1.1 Teva Pharmaceutical Industries Ltd.
19.1.2 Emergent Biosolutions
19.1.3 Sanofi Pasteur, Inc.
19.1.4 GlaxoSmithKline
19.1.5 Merck & Co., Inc.
19.1.6 CSL Limited
19.1.7 Astrazeneca
19.1.8 Pfizer
19.1.9 Serum Institute Of India Pvt. Ltd.
19.1.10 Protein Sciences Corporation
2. EXECUTIVE SUMMARY
3. STRATEGIC RECOMMENDATION
3.1. Escalate the focus on the Asia Pacific Region
3.2. Focus on R&D
4. GLOBAL ANTI-INFECTIVE VACCINES MARKET: PRODUCT OVERVIEW
5. GLOBAL ANTI-INFECTIVE VACCINES MARKET: GROWTH AND FORECAST
5.1 Global Anti-infective Vaccines Market
5.1.1. By Value (Historic 2011-15)
5.1.2. By Value ( Forecast 2016E-2021F)
6. GLOBAL ANTI-BACTERIAL VACCINES MARKET: GROWTH AND FORECAST
6.1 Global Anti-Bacterial Vaccines Market
6.1.1. By Value(Historic 2011-15)
6.1.2 By Value( Forecast 2016E-2021F)
7. GLOBAL ANTI-VIRAL VACCINES MARKET: GROWTH AND FORECAST
7.1 Global Anti-Viral Vaccines Market
7.1.1 By Value(Historic 2011-15)
7.1.2 By Value( Forecast 2016E-2021F)
8. GLOBAL ANTI-INFECTIVE VACCINES MARKET - BY DISEASE
8.1 Global Typhoid Vaccines Market
8.1.1. By Value-Actual(2015)
8.1.2. By Value-Forecast(2021)
8.2 Global Tuberculosis Vaccines Market
8.2.1. By Value-Actual(2015)
8.2.2. By Value -Forecast(2021)
8.3 Global Other Anti-Bacterial Vaccines Market
8.3.1. By Value-Actual(2015)
8.3.2 By Value- Forecast (2021)
8.4 Global Influenza Vaccines Market
8.4.1. By Value-Actual(2015)
8.4.2 By Value- Forecast (2021)
8.5 Global Hepatitis Vaccines Market
8.5.1 By Value-Actual(2015)
8.5.2 By Value- Forecast (2021)
8.6 Global Other Anti-Viral Vaccines Market
8.6.1 By Value-Actual(2015)
8.6.2 By Value- Forecast (2021)
9. GLOBAL ANTI-INFECTIVE VACCINES- PIPELINE ANALYSIS
9.1 Typhoid Vaccines
9.2 Tuberculosis Vaccines
9.3 Tetanus & Diptheria Vaccines
9.4 Other Anti-Bacterial Vaccines
9.5 Influenza Vaccines
9.6 Hepatitis Vaccines
9.7 Polio Vaccines
9.8 Other Anti-Viral Vaccines
10. NORTH AMERICA ANTI-INFECTIVE VACCINES MARKET: SIZING AND GROWTH
10.1 By Value-Actual(2015)
10.2 By Value- Forecast (2021)
10.3 North America Anti-Bacterial Vaccines Market
10.3.1 By Value-Actual(2015)
10.3.2 By Value- Forecast (2021)
10.4 North America Anti-Viral Vaccines Market
10.4.1 By Value-Actual(2015)
10.4.2 By Value Forecast ( 2016-2021)
11. NORTH AMERICA ANTI-INFECTIVE VACCINES MARKET- BY DISEASE
11.1 North America Typhoid Vaccines Market
11.1.1 By Value-Actual(2015)
11.1.2 By Value- Forecast (2021)
11.2 North America Tuberculosis Vaccines Market
11.2.1 By Value-Actual(2015)
11.2.2 By Value- Forecast (2021)
11.3 North America Other Anti-Bacterial Vaccines Market
11.3.1 By Value-Actual(2015)
11.3.2 By Value- Forecast (2021)
11.4 North America Influenza Vaccines Market
11.4.1 By Value-Actual(2015)
11.4.2 By Value- Forecast (2021)
11.5 North America Hepatitis Vaccines Market
11.5.1 By Value – Actual ( 2011-2015)
11.5.2 By Value Forecast ( 2016-2021)
11.6 North America Other Anti-Viral Vaccines Market
11.6.1 By Value-Actual(2011-2015)
11.6.2 By Value- Forecast (2016-2021)
11.7 US Anti-Infective Vaccines Market
11.7.1 By Value-Actual(2011-2015)
11.7.2 By Value- Forecast (2016-2021)
11.8 US Anti-Bacterial Vaccines Market
11.8.1 By Value-Actual(2011-2015)
11.8.2 By Value- Forecast (2016-2021)
11.9 US Anti-Viral Vaccines Market
11.9.1 By Value-Actual(2015)
11.9.2 By Value- Forecast (2021)
11.10 Canada Anti-Infective Vaccines Market
11.10.1 By Value-Actual(2011-2015)
11.10.2 By Value- Forecast (2016-2021)
11.13 North America Others Market
11.13.1 By Value-Actual(2011-2015)
11.13.2 By Value- Forecast (2016-2021)
12. EUROPE ANTI-INFECTIVE VACCINES MARKET: SIZING AND GROWTH
12.1 By Value-Actual(2015)
12.2 By Value- Forecast (2021)
12.3 Europe Anti-Bacterial Vaccines Market
12.3.1 By Value-Actual(2015)
12.3.2 By Value- Forecast (2021)
12.4 Europe Anti-Viral Vaccines Market
12.4.1 By Value-Actual(2015)
12.4.2 By Value Forecast ( 2016-2021)
13. EUROPE ANTI-INFECTIVE VACCINES MARKET- BY DISEASE
13.1 Europe Typhoid Vaccines Market
13.1.1 By Value-Actual(2015)
13.1.2 By Value- Forecast (2021)
13.2 Europe Tuberculosis Vaccines Market
13.2.1 By Value-Actual(2015)
13.2.2 By Value- Forecast (2021)
13.3 Europe Other Anti-Bacterial Vaccines Market
13.3.1 By Value-Actual(2015)
13.3.2 By Value- Forecast (2021)
13.4 Europe Influenza Vaccines Market
13.4.1 By Value-Actual(2015)
13.4.2 By Value- Forecast (2021)
13.5 Europe Hepatitis Vaccines Market
13.5.1 By Value – Actual ( 2011-2015)
13.5.2 By Value Forecast ( 2016-2021)
13.6 Europe Other Anti-Viral Vaccines Market
13.6.1 By Value-Actual (2011-2015)
13.6.2 By Value- Forecast (2016-2021)
13.7 UK Anti-Infective Vaccines Market
13.7.1 By Value-Actual(2011-2015)
13.7.2 By Value- Forecast (2016-2021)
13.8 UK Anti-Bacterial Vaccines Market
13.8.1 By Value-Actual(2011-2015)
13.8.2 By Value- Forecast (2016-2021)
13.9 UK Anti-Viral Vaccines Market
13.9.1 By Value-Actual(2015)
13.9.2 By Value- Forecast (2021)
13.10 France Anti-Infective Vaccines Market
13.10.1 By Value-Actual(2011-2015)
13.10.2 By Value- Forecast (2016-2021)
13.11 France Anti-Bacterial Vaccines Market
13.11.1 By Value-Actual(2011-2015)
13.11.2 By Value- Forecast (2016-2021)
13.12 France Anti-Viral Vaccines Market
13.12.1 By Value-Actual (2015)
13.12.2 By Value- Forecast (2021)
13.13 Europe Others Market
13.13.1 By Value-Actual(2011-2015)
13.13.2 By Value- Forecast (2016-2021)
14. APAC ANTI-INFECTIVE VACCINES MARKET: SIZING AND GROWTH
14.1 By Value-Actual(2015)
14.2 By Value- Forecast (2021)
14.3 APAC Anti-Bacterial Vaccines Market
14.3.1 By Value-Actual(2015)
14.3.2 By Value- Forecast (2021)
14.4 Europe Anti-Viral Vaccines Market
14.4.1 By Value-Actual(2015)
14.4.2 By Value Forecast ( 2016-2021)
15. APAC ANTI-INFECTIVE VACCINES MARKET- BY DISEASE
15.1 APAC Typhoid Vaccines Market
15.1.1 By Value-Actual(2015)
15.1.2 By Value- Forecast (2021)
15.2 APAC Tuberculosis Vaccines Market
15.2.1 By Value-Actual(2015)
15.2.2 By Value- Forecast (2021)
15.3 APAC Other Anti-Bacterial Vaccines Market
15.3.1 By Value-Actual(2015)
15.3.2 By Value- Forecast (2021)
15.4 APAC Influenza Vaccines Market
15.4.1 By Value-Actual(2015)
15.4.2 By Value- Forecast (2021)
15.5 APAC Hepatitis Vaccines Market
15.5.1 By Value – Actual ( 2011-2015)
15.5.2 By Value Forecast ( 2016-2021)
15.6 APAC Other Anti-Viral Vaccines Market
15.6.1 By Value-Actual(2011-2015)
15.6.2 By Value- Forecast (2016-2021)
15.7 India Anti-Infective Vaccines Market
15.7.1 By Value-Actual(2011-2015)
15.7.2 By Value- Forecast (2016-2021)
15.8 India Anti-Bacterial Vaccines Market
15.8.1 By Value-Actual(2011-2015)
15.8.2 By Value- Forecast (2016-2021)
15.9 India Anti-Viral Vaccines Market
15.9.1 By Value-Actual(2015)
15.9.2 By Value- Forecast (2021)
15.10 China Anti-Infective Vaccines Market
15.10.1 By Value-Actual(2011-2015)
15.10.2 By Value- Forecast (2016-2021)
15.11 China Anti-Bacterial Vaccines Market
15.11.1 By Value-Actual(2011-2015)
15.11.2 By Value- Forecast (2016-2021)
15.12 China Anti-Viral Vaccines Market
15.12.1 By Value-Actual(2015)
15.12.2 By Value- Forecast (2021)
15.13 APAC Others Market
15.13.1 By Value-Actual(2011-2015)
15.13.2 By Value- Forecast (2016-2021)
16. ROW ANTI-INFECTIVE VACCINES MARKET
16.1 By Value-Actual(2015)
16.2 By Value- Forecast (2021)
17. MARKET DYNAMICS
17.1. Drivers
17.2. Challenges
17.3. Trends
18. POLICY AND REGULATORY LANDSCAPE
19. COMPETITIVE LANDSCAPE
19.1. Company Profiles
19.1.1 Teva Pharmaceutical Industries Ltd.
19.1.2 Emergent Biosolutions
19.1.3 Sanofi Pasteur, Inc.
19.1.4 GlaxoSmithKline
19.1.5 Merck & Co., Inc.
19.1.6 CSL Limited
19.1.7 Astrazeneca
19.1.8 Pfizer
19.1.9 Serum Institute Of India Pvt. Ltd.
19.1.10 Protein Sciences Corporation
LIST OF FIGURES
Figure 1: Global Anti-infective Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 2: Global Anti-infective Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 3: Global Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 4: Global Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 5: Global Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 6: Global Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 7: Global Typhoid Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 8: Global Typhoid Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 9: Global Tuberculosis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 10: Global Tuberculosis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 11: Global Other Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 12: Global Other Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 13: Global Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 14: Global Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 15: Global Hepatitis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 16: Global Hepatitis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 17: Global Other Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 18: Global Other Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 19: North America Anti-infective Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 20: North America Anti-infective Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 21: North America Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 22: North America Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 23: North America Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 24: North America Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 25: North America Typhoid Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 26: North America Typhoid Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 27: North America Tuberculosis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 28: North America Tuberculosis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 29: North America Other Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 30: North America Other Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 31: North America Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 32: North America Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 33: North America Hepatitis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 34: North America Hepatitis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 35: North America Other Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 36: North America Other Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 37: US Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 38: US Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 39: US Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 40: Canada Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 41: Canada Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 42: Canada Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Million)
Figure 43: North America Others Anti-Infective Vaccines Market Size, By Value, 2011-2021 (USD Billion)
Figure 44: Europe Anti-Infective Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 45: Europe Anti-infective Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 46: Europe Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 47: Europe Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 48: Europe Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 49: Europe Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 50: Europe Typhoid Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 51: Europe Typhoid Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 52: Europe Tuberculosis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 53: Europe Tuberculosis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 54: Europe Other Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 55: Europe Other Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 56: Europe Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 57: Europe Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 58: Europe Hepatitis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 59: Europe Hepatitis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 60: North America Other Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 61: Europe Other Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 62: UK Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 63: UK Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 64: UK Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 65: France Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 66: France Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 67: France Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 68: Europe Others Anti-Infective Vaccines Market Size, By Value, 2011-2021 (USD Billion)
Figure 69: APAC Anti-infective Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 70: APAC Anti-infective Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 71: APAC Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 72: APAC Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 73: North America Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 74: APAC Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 75: APAC Typhoid Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 76: North America Typhoid Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 77: APAC Tuberculosis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 78: APAC Tuberculosis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 79: APAC Other Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 80: APAC Other Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 81: APAC Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 82: APAC Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 83: APAC Hepatitis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 84: APAC Hepatitis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 85: North America Other Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 86: APAC Other Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 87: India Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 88: India Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 89: India Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 90: China Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 91: China Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 92: China Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 93: APAC other’s Anti-Infective Vaccines Market Size, By Value, 2011-2021 (USD Billion)
Figure 94: ROW Market Size, By Value, 2011-2015 (USD Million)
Figure 95: ROW Market Size, By Value, 2016E-2021F (USD Million)
Figure 1: Global Anti-infective Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 2: Global Anti-infective Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 3: Global Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 4: Global Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 5: Global Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 6: Global Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 7: Global Typhoid Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 8: Global Typhoid Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 9: Global Tuberculosis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 10: Global Tuberculosis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 11: Global Other Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 12: Global Other Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 13: Global Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 14: Global Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 15: Global Hepatitis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 16: Global Hepatitis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 17: Global Other Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 18: Global Other Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 19: North America Anti-infective Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 20: North America Anti-infective Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 21: North America Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 22: North America Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 23: North America Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 24: North America Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 25: North America Typhoid Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 26: North America Typhoid Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 27: North America Tuberculosis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 28: North America Tuberculosis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 29: North America Other Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 30: North America Other Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 31: North America Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 32: North America Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 33: North America Hepatitis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 34: North America Hepatitis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 35: North America Other Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 36: North America Other Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 37: US Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 38: US Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 39: US Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 40: Canada Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 41: Canada Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 42: Canada Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Million)
Figure 43: North America Others Anti-Infective Vaccines Market Size, By Value, 2011-2021 (USD Billion)
Figure 44: Europe Anti-Infective Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 45: Europe Anti-infective Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 46: Europe Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 47: Europe Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 48: Europe Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 49: Europe Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 50: Europe Typhoid Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 51: Europe Typhoid Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 52: Europe Tuberculosis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 53: Europe Tuberculosis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 54: Europe Other Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 55: Europe Other Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 56: Europe Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 57: Europe Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 58: Europe Hepatitis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 59: Europe Hepatitis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 60: North America Other Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 61: Europe Other Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 62: UK Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 63: UK Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 64: UK Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 65: France Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 66: France Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 67: France Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 68: Europe Others Anti-Infective Vaccines Market Size, By Value, 2011-2021 (USD Billion)
Figure 69: APAC Anti-infective Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 70: APAC Anti-infective Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 71: APAC Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 72: APAC Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 73: North America Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 74: APAC Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 75: APAC Typhoid Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 76: North America Typhoid Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 77: APAC Tuberculosis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 78: APAC Tuberculosis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 79: APAC Other Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 80: APAC Other Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 81: APAC Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 82: APAC Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 83: APAC Hepatitis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 84: APAC Hepatitis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 85: North America Other Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Figure 86: APAC Other Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Figure 87: India Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 88: India Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 89: India Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 90: China Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 91: China Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 92: China Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
Figure 93: APAC other’s Anti-Infective Vaccines Market Size, By Value, 2011-2021 (USD Billion)
Figure 94: ROW Market Size, By Value, 2011-2015 (USD Million)
Figure 95: ROW Market Size, By Value, 2016E-2021F (USD Million)
LIST OF TABLES
Table 1:Typhoid Vaccines – Pipeline Products (Company and Stages)
Table 2:Tuberculosis Vaccines – Pipeline Products (Company and Stages)
Table 3:Tetanus and Diptheria Vaccines – Pipeline Products (Company and Stages)
Table 1:Typhoid Vaccines – Pipeline Products (Company and Stages)
Table 2:Tuberculosis Vaccines – Pipeline Products (Company and Stages)
Table 3:Tetanus and Diptheria Vaccines – Pipeline Products (Company and Stages)
